AI医疗科技公司FluidAI Medical近日宣布，已成功筹集1500万美元的A轮融资，由SOSV和Graphene Ventures领投。FluidAI Medical是利用人工智能进行术后患者监测的先驱，本次融资将主要用于该公司的发展和扩大。
FluidAI Medical成立于2018年，致力于利用AI技术提高医疗效率和质量。公司的产品可以帮助医生实时监测患者的生命体征，提高手术的成功率和患者康复速度。自成立以来，FluidAI Medical已为全球多家医疗机构提供服务，并取得了显著的成果。
本次融资将帮助FluidAI Medical继续开发和完善其产品，扩大市场占有率，并寻求更多的合作伙伴。随着AI技术在医疗领域的广泛应用，FluidAI Medical有望成为该领域的重要参与者。
英文翻译：
AI medical company FluidAI Medical has recently announced that it has successfully raised $15 million in Series A financing, led by SOSV and Graphene Ventures. FluidAI Medical is a pioneer in the use of AI for post-surgery patient monitoring, and the funds raised will be used to further develop and expand the company.
FluidAI Medical was founded in 2018 with the mission of improving medical efficiency and quality through the use of AI technology. The company’s product enables doctors to monitor patients’ vital signs in real-time, increasing the success rate of surgery and improving patients’ recovery times. Since its inception, FluidAI Medical has provided services to healthcare institutions around the world and has achieved significant results.
This round of financing will help FluidAI Medical continue to develop and improve its products, expand its market share, and seek out more partners. With the widespread application of AI technology in the healthcare field, FluidAI Medical is expected to become an important player in the industry.
【来源】https://www.prnewswire.com/news-releases/fluidai-medical-announces-15m-in-series-a-funding-for-ai-driven-postoperative-monitor-at-hlth-2023-301951883.html
Views: 1